Design Therapeutics director gets 30,000 stock options
Design Therapeutics director and 10% owner George Simeon received a grant of stock options covering 30,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Design Therapeutics director and 10% owner George Simeon received a grant of stock options covering 30,000 shares of common stock. The options have an exercise price of $10.55 per share and expire on June 8, 2036. They vest in equal monthly installments over 12 months after June 9, 2026, or will be fully vested by the company’s next annual stockholder meeting.
Insider Trade Summary
Grant/Award: 30,000 shares
Grant/Award
1 txn
Insider
George Simeon
Role
Director, 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 30,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 30,000 contracts (Direct)
Footnotes (1)
- F1. The shares subject to the option vest in equal monthly installments over 12 months following June 9, 2026 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders.
Key Figures
Option grant size: 30,000 options
Exercise price: $10.55 per share
Expiration date: June 8, 2036
+2 more
5 metrics
Option grant size
30,000 options
Stock Option (right to buy) granted to George Simeon
Exercise price
$10.55 per share
Exercise price of stock options on common stock
Expiration date
June 8, 2036
Option expiration for Simeon’s grant
Vesting period
12 months
Equal monthly vesting after June 9, 2026
Total options after grant
30,000 options
Total derivative securities following transaction
Key Terms
Stock Option (right to buy), exercise price, vesting, expiration date
4 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy) granted on June 9, 2026"
exercise price financial
"conversion_or_exercise_price of the option is 10.5500 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares subject to the option vest in equal monthly installments over 12 months"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date for the option is 2036-06-08T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Design Therapeutics (DSGN) report for George Simeon?
Design Therapeutics reported that director and 10% owner George Simeon received a grant of stock options for 30,000 shares of common stock. This is a compensation-related award, not an open-market purchase or sale of existing shares.
What is the exercise price of the new DSGN stock options granted to George Simeon?
The granted stock options have an exercise price of $10.55 per share. This means Simeon can buy Design Therapeutics common stock at $10.55 when the options are vested and exercised, regardless of the market price at that time.
When do George Simeon’s DSGN stock options vest and become exercisable?
The options vest in equal monthly installments over 12 months following June 9, 2026. However, the filing states they will in any case be fully vested on the date of Design Therapeutics’ next annual meeting of stockholders, if that occurs earlier.
What is the expiration date of the Design Therapeutics (DSGN) options granted to George Simeon?
The stock options granted to George Simeon expire on June 8, 2036. After that expiration date, Simeon would no longer be able to exercise these options to purchase Design Therapeutics common stock at the specified exercise price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates